Redhill Biopharma Ltd (NASDAQ:RDHL)
| 0.7204 Delayed Data As of Sep 22 |  -0.0338 / -4.44%Today’s Change | 0.70 Today|||52-Week Range 38.40 | -87.16% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 3.0K | 101.3K | 4.0M | 8.3M | |
| Cost of Goods Sold | 0.00 | -- | 2.1M | 2.7M | ||
| Depreciation And Amortization | 36.0K | 44.1K | 81.6K | 89.7K | ||
| Operating Expenses | Gross Income | -33.0K | -- | 1.9M | 5.5M | |
| General Expenses | 21.9M | 30.7M | 53.4M | 44.7M | ||
| Research And Development | 17.8M | 25.3M | 33.2M | 24.8M | ||
| Total Operating Expenses | 21.9M | 30.7M | 55.5M | 47.5M | ||
| Non-Operating Expenses | Operating Income | -21.9M | -30.6M | -51.5M | -39.2M | |
| Extraordinary Credit | 887.7K | 1.2M | 5.7M | 397.7K | ||
| Extraordinary Charge | -100.0K | -369.2K | -851.0K | -- | ||
| Other Expenses | -211.9K | 27.1K | 447.2K | -166.5K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -21.1M | -29.5M | -45.9M | -38.7M | |
| Net Income | -21.1M | -29.5M | -45.9M | -38.7M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 11.1M | 12.9M | 17.7M | 23.1M | |
| Shares To Calculate EPS Diluted | 11.2M | 12.9M | 17.7M | 23.1M | ||
| Earnings Per Share | EPS | -$1.90 | -$2.31 | -$2.62 | -$1.67 | |
| EPS Diluted | -$1.90 | -$2.41 | -$2.62 | -$1.67 | ||
